Kewalramani Reshma 4

What Happened
Reshma Kewalramani, CEO, President and Director of Vertex Pharmaceuticals (VRTX), had 4,981 shares disposed on February 24, 2026 to satisfy tax withholding obligations. The shares were valued at $485.11 each, for a total withholding value of $2,416,333. This was a tax-withholding/tax payment transaction (not an open-market sale).

Key Details

• Transaction date: 2026-02-24; price per share: $485.11; total value: $2,416,333.
• Transaction type/code: F — payment of exercise price or tax liability (shares withheld to cover taxes).
• Shares owned after the transaction: not specified in the provided excerpt of the filing (see full Form 4 for post-transaction holdings).
• Filing date: 2026-02-26 — appears to be filed within the Form 4 two-business-day reporting window.
• Notable: This is a withholding for taxes (routine administrative disposition), not an open-market sale that would represent a directional trade.

Context
Tax-withholding disposals commonly occur when an executive exercises options or vesting shares are issued and the company withholds a portion to cover tax obligations (a cashless/tax-withholding outcome). Such transactions are administrative and do not necessarily signal the insider’s view on the company’s stock. For full details and any linked option exercise or vesting event, review the complete Form 4 filing.